<DOC>
	<DOCNO>NCT02297100</DOCNO>
	<brief_summary>The purpose research study identify optimal usage Onabotulinumtoxin A interstitial cystitis . Onabotulinumtoxin A , commonly know trade name BotoxÂ® , medication come bacteria Clostridium botulinum . It work block release neurotransmitter acetylcholine ( chemical messenger carry signal nerve cell cell body ) . Blocking neurotransmitter result decrease muscle activity .</brief_summary>
	<brief_title>Intravesicular Onabotulinumtoxin A Interstitial Cystitis</brief_title>
	<detailed_description>The purpose study evaluate efficacy intravesicular Onabotulinumtoxin A injection treatment interstitial cystitis ( IC ) . Specifically , hypothesize trigonal Onabotulinumtoxin A injection effective treatment IC result subjective objective symptom relief posterior wall Onabotulinumtoxin A injection .</detailed_description>
	<mesh_term>Cystitis</mesh_term>
	<mesh_term>Cystitis , Interstitial</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>1 . Adult female age 18 80 inclusive 2 . Patients treat IC refractory conservative management oral therapy . 3. willing able initiate catheterization posttreatment 1 . Any history bladder cancer , uterine cancer , ovarian cancer , vaginal cancer , urethral diverticulum , spinal cord injury , stroke , Parkinson 's disease , multiple sclerosis , spina bifida , cyclophosphamide treatment , radiation treatment pelvis , bladder tuberculosis , genital herpes . 2 . Currently require antiplatelet/anticoagulant concomitant therapy antiplatelet/ anticoagulant therapy within past 3 month 3 . Pregnancy . Pregnancy absolute contraindication undergoing procedure . Thus , part normal preoperative work , standard care , pregnancy test administer woman childbearing age , sexually active , within 10 day normal menstrual period . If positive , exclude undergo procedure . 4 . An active urinary tract infection show cleancatch urinalysis screen visit . Subject may rescreened UTI successfully treat urinalysis negative rescreening . 5 . A history hypersensitivity allergy botulinum toxin preparation 6 . A postvoid residual ( PVR ) urine volume &gt; 200mL baseline 7 . Treatment botulinum toxin 12 week period prior trial</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>woman</keyword>
	<keyword>interstitial cystitis</keyword>
	<keyword>bladder pain syndrome</keyword>
	<keyword>botox</keyword>
	<keyword>onabotulinum toxin A</keyword>
</DOC>